82 related articles for article (PubMed ID: 798193)
1. Toleration and bioavailability of gemfibrozil in healthy men.
Smith TC
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):24-7. PubMed ID: 798193
[No Abstract] [Full Text] [Related]
2. Preliminary observations on the effect of gemfibrozil on the excretion of faecal bile acids.
Baird IM; Lewis B; Hill JM
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):112-4. PubMed ID: 1019150
[No Abstract] [Full Text] [Related]
3. Structure/activity relationship of gemfibrozil (CI-719) and related compounds.
Creger PL; Moersch GW; Neuklis WA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):3-5. PubMed ID: 1019152
[No Abstract] [Full Text] [Related]
4. Gemfibrozil: a new lipid lowering agent. Open forum.
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):115-20. PubMed ID: 1019151
[No Abstract] [Full Text] [Related]
5. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
Børresen AL; Berg K; Dahlén G; Gillnäs T; Ericson C
Artery; 1981; 9(1):77-86. PubMed ID: 7018466
[TBL] [Abstract][Full Text] [Related]
6. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Rodney G; Uhlendorf P; Maxwell RE
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
[No Abstract] [Full Text] [Related]
7. Hypolipidaemic action of gemfibrozil in adult nephrotics.
Eisalo A; Manninen V; Mälkönen M; Kuhlbäck B
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):47-8. PubMed ID: 798197
[No Abstract] [Full Text] [Related]
8. Lipokinetic studies with gemfibrozil (CI-719).
Kissebah AH; Adams PA; Wynn V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):94-7. PubMed ID: 190610
[TBL] [Abstract][Full Text] [Related]
9. Effect of gemfibrozil on lipolysis in dogs in vivo.
Riemersma RA; Oliver MF
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):107-8. PubMed ID: 1019148
[No Abstract] [Full Text] [Related]
10. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
Lageder H; Irsigler K
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
[No Abstract] [Full Text] [Related]
11. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
[TBL] [Abstract][Full Text] [Related]
12. Properties of sterol biosynthesis in human leukocytes: effects of gemfibrozil.
Betteridge DJ; Higgins MJ; Galton DJ
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):104-6. PubMed ID: 190606
[No Abstract] [Full Text] [Related]
13. Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.
Rasi VP; Torstila I
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):109-11. PubMed ID: 1019149
[No Abstract] [Full Text] [Related]
14. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
Honorato J; Masso RM; Purroy A
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
[No Abstract] [Full Text] [Related]
15. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
[No Abstract] [Full Text] [Related]
16. Toxicological studies on gemfibrozil.
Kurtz SM; Fitzgerald JE; Fisken RA; Schardein JL; Reutner TH; Lucas JA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):15-23. PubMed ID: 828262
[No Abstract] [Full Text] [Related]
17. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
[No Abstract] [Full Text] [Related]
18. Effect of gemfibrozil on serum lipid levels.
Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
Artery; 1980; 7(3):224-31. PubMed ID: 7008748
[TBL] [Abstract][Full Text] [Related]
19. Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil.
Fitzgerald JE; Sanyer JL; Schardein JL; Lake RS; McGuire EJ; de la Iglesia FA
J Natl Cancer Inst; 1981 Nov; 67(5):1105-16. PubMed ID: 7029098
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Vessby B; Lithell H; Boberg J; Hellsing K; Werner I
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
